RN7SL632P

Across TCGA pan-cancer cohorts, RN7SL632P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RN7SL632P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SL632P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL632P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

BLCA, OV, and LUSC are the cancer types where RN7SL632P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.148	0.577	<.001	63	view →
OV	DFS	Tertile	IV	0.100	0.464	.044	18	view →
LUSC	OS	Tertile	All	0.140	0.407	.006	18	view →
LUAD	OS	Tertile	All	0.681	0.794	.016	12	view →
ACC	OS	Tertile	All	0.149	0.686	.047	9	view →
STAD	OS	Tertile	II,III,IV	0.762	0.615	.017	8	view →
SARC	OS	Tertile	All	0.713	0.840	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RN7SL632P–BLCA (DFS)

Open the BLCA breakdown →